Company CVAbout Vineet Laboratories Ltd 
Vineet Laboratories Ltd
Micro Cap
Pharmaceuticals & Drugs
Vineet Laboratories Limited (Formerly known as Ortin Laboratories Limited) is a manufacturing company of intermediates useful for the manufacture of active pharmaceutical ingredients. The Company was incorporated on 10 November 2016 and operates in the business of in the manufacture of Drug Intermediates & Bulk Dugs.
Company Coordinates
Company Details
SyNo 11/A3 Saheb Nagar KurduVi, Chintal Kunta Eshwaramma LB Nr Hyderabad Telangana : 500074
Registrar Details
Capital StructureCapital Structure
Present Equity Capital
INR 9.22 Cr
Number of Shares
92.19 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
02-Feb-2021
92.19
9.22
8809008
10
Scheme of Arrangement
02-Feb-2021
92.19
9.22
8809008
10
Scheme of Arrangement
05-Jun-2018
4.1
0.41
400000
10
Preferential Allotment
05-Jun-2018
4.1
0.41
400000
10
Preferential Allotment
10-Nov-2016
1
0.01
10000
10
Subscriber to MOA
10-Nov-2016
1
0.01
10000
10
Subscriber to MOA
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Non Institution
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 0 FIIs
Promoter with highest holding
Venkata Ramana Gaddam (9.01%)
Highest Public shareholder
Rajesh Poddar (4.48%)
Individual Investors Holdings
59.33%
Board of Directors
Management
Designation
Remuneration
Gaddam Venkata Ramana
Managing Director
33.0 lacs
Bhupathiraju S Raju
Whole Time Director & CFO
27.0 lacs
Kandula Murali Mohan
Non Executive Director
0
Dilip V Acharekar
Independent Director
0
K. Bhaskar Reddy
Independent Director
0
Nirosha Ravikanti
Company Secretary
0
Yerukalapudi Hari Priya
Additional Director
0
Rameshkumar Bandari
Company Sec. & Compli. Officer
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
No Data Available for Finished Goods Segmentation
No Data Available
Stock DNARevenue and Profits:
Net Sales:
18 Cr
(Quarterly Results - Dec 2024)
Net Profit:
-6 Cr
Pharmaceuticals & Drugs
INR 32 Cr (Micro Cap)
NA (Loss Making)
33
0.00%
1.55
-30.93%
1.29
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
